Consolidated Statements of Assets and Liabilities - USD ($)		Dec. 31, 2024	Dec. 31, 2023
Investments at fair value:
Investments at fair value	[1]	$ 377,640,318	$ 376,992,972
Cash		4,028,665	5,045,540
Interest receivable		3,887,028	3,291,794
Deferred financing cost		2,169,211	846,916
Paydown receivable		341,471	1,068,839
Prepaid expenses		6,748	0
Total assets		388,073,441	387,246,061
LIABILITIES
Credit facility payable		122,500,000	176,500,000
Deferred tax liabilities		6,094,196	0
Redemptions payable		5,637,890	4,700,693
Distributions payable		5,322,771	6,073,111
Incentive fees payable, net of fee waivers (Note 6)		2,813,724	3,961,476
Credit facility interest payable		2,267,199	3,645,612
Management fees payable, net of fee waivers (Note 6)		1,157,509	1,121,412
Professional fees payable		434,744	308,137
Other payables		900,145	368,999
Reimbursement expense payable		77,275	79,070
Legal fees payable		37,883	26,962
Total liabilities		147,243,336	196,785,472
Commitments and contingencies (Note 11)
NET ASSETS
Common shares, $0.001 par value (200,000,000 shares authorized, 9,857,301 and 7,687,482 shares issued and outstanding as of December 31, 2024 and December 31, 2023 respectively)		9,858	7,688
Contribution receivable		0	(110,891)
Additional paid-in capital		246,622,366	191,646,036
Accumulated undistributed (overdistributed) earnings		(5,802,119)	(1,082,244)
Total net assets		$ 240,830,105	$ 190,460,589
Net asset value per share (in dollars per share)		$ 24.43	$ 24.78
Non-controlled/Non-affiliate Investments [Member]
Investments at fair value:
Investments at fair value		$ 326,959,520	$ 367,622,559
Controlled/Affiliate Investments [Member]
Investments at fair value:
Investments at fair value		$ 50,680,798	$ 9,370,413

[1] Because there is no readily available market value for these investments, the fair value of each of these investments is determined in good faith using significant unobservable inputs by the Company’s board of directors (the “Board”) as required by the 1940 Act. See Note 4 "Fair Value Measurements" in the accompanying notes to the consolidated financial statements.